Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
NCT ID: NCT03453645
Last Updated: 2018-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2017-09-09
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SMART Identification of Ventricular Tachycardia Isthmus
NCT04852497
Preventive VT Substrate Ablation in Ischemic Heart Disease
NCT04675073
Functional Substrate-Only Guided VT Ablation
NCT06464315
A Study of Early Robotic Ablation by Substrate Elimination of Ventricular Tachycardia
NCT01182389
Late Potentials and Ablation Index in Ventricular Tachycardia Ablation
NCT03437408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Rhythmic risk assessment criterions have never been studied in relation with ventricular tachycardia ablation. The purpose of this study is to explore the modifications of these criterions after ventricular tachycardia ablation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ventricular tachycardia ablation
The usual organization of hospitalization of the patients addressed for ventricular tachycardia ablation and his follow-up are not modified by the protocol. .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with ischemic cardiomyopathy according to European Society of Cardiology Guidelines,
* patients with implanted cardiac defibrillator.
Exclusion Criteria
* permanent atrial fibrillation,
* permanent ventricular pacing,
* left bundle block.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe MAURY, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A00582-51
Identifier Type: OTHER
Identifier Source: secondary_id
RC31/17/0066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.